PeriphaGen
Dr. Loprinzi is an oncologist and noted expert in breast cancer prevention and symptom control. He has been involved in the design and execution of over a dozen CIPN clinical trials.
This person is not in the org chart
This person is not in any offices
PeriphaGen
PeriphaGen is a biopharmaceutical company focused on peripheral nerve gene therapy and committed to the development of innovative products for difficult-to-treat neurological disorders thereby improving patients' quality of life.